Leksell vantage stereotactic system

Ended Purchase Order Awarded Last action

Contract number
75N90023P00805
Awardee
Awarding agency
Obligated
$308,297

Award facts

Contract value 100% obligated
$308,296.76 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $21,456
Original award $286,841

About this award

The Department of Health and Human Services National Institutes of Health Clinical Center (HHS-NIH) awarded a $308,296.76 purchase order to Elekta Inc., doing business as Elekta, for the provision of a LEKSELL VANTAGE STEREOTACTIC SYSTEM. The place of performance will be in Bethesda, Maryland, with a start date of September 25, 2023 and an end date of October 25, 2023. The contract utilizes a firm fixed price type of pricing. No subcontractors were identified. The LEKSELL VANTAGE STEREOTACTIC SYSTEM is a stereotactic device used in neurosurgery to noninvasively deliver radiation therapy to the brain and other parts of the body.

Quick answers

Who was awarded contract 75N90023P00805?

75N90023P00805 was awarded to Elekta Inc. by NIH Clinical Center (National Institutes of Health) on September 25, 2023.

How much is contract 75N90023P00805 worth?

The government has obligated $308,297 on 75N90023P00805.

Was contract 75N90023P00805 competed?

The extent of competition for 75N90023P00805 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award